Morbidity and Mortality Weekly Report (MMWR), March 1, 2013; 62(08);148-151
16 pp. 680 kB:
In 2011 the Malawi Ministry of Health (MOH) implemented an innovative approach (called “Option B+”), in which all HIV-infected pregnant and breastfeeding women are eligible for lifelong antiretroviral therapy (ART) regardless of CD4 count. The number of pregnant and breastfeeding women started on ART per quarter increased by 748%, from 1,257 in the second quarter of 2011 (before Option B+ implementation) to 10,663 in the third quarter of 2012 (1 year after implementation). Option B+ is an important innovation that could accelerate progress in Malawi and other countries toward the goal of eliminating mother-to-child transmission of HIV worldwide.